应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02480 绿竹生物-B
休市中 04-19 16:08:35
20.500
+0.450
+2.24%
最高
20.500
最低
20.500
成交量
1,600
今开
20.500
昨收
20.050
日振幅
0.00%
总市值
41.50亿
流通市值
41.50亿
总股本
2.02亿
成交额
3.28万
换手率
0.00%
流通股本
2.02亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
绿竹生物-B(02480)股价下跌8.061%,现价港币$18.02
阿斯达克财经 · 04-12
绿竹生物-B(02480)股价下跌8.061%,现价港币$18.02
绿竹生物-B盘中异动 急速下挫6.13%报18.400港元
自选股智能写手 · 04-12
绿竹生物-B盘中异动 急速下挫6.13%报18.400港元
绿竹生物:LZ901研发稳步推进 未来盈利空间值得期待
中国财富通 · 04-11
绿竹生物:LZ901研发稳步推进 未来盈利空间值得期待
绿竹生物-B盘中异动 临近午盘股价大跌5.56%报17.000港元
自选股智能写手 · 03-25
绿竹生物-B盘中异动 临近午盘股价大跌5.56%报17.000港元
绿竹生物-B(02480)股价下跌5.556%,现价港币$17.0
阿斯达克财经 · 03-25
绿竹生物-B(02480)股价下跌5.556%,现价港币$17.0
绿竹生物-B盘中异动 急速下挫5.32%
自选股智能写手 · 03-21
绿竹生物-B盘中异动 急速下挫5.32%
绿竹生物-B(02480)股价下跌5.319%,现价港币$17.8
阿斯达克财经 · 03-21
绿竹生物-B(02480)股价下跌5.319%,现价港币$17.8
绿竹生物-B盘中异动 下午盘股价大跌5.06%报18.000港元
自选股智能写手 · 03-20
绿竹生物-B盘中异动 下午盘股价大跌5.06%报18.000港元
绿竹生物-B(02480)股价下跌5.063%,现价港币$18.0
阿斯达克财经 · 03-20
绿竹生物-B(02480)股价下跌5.063%,现价港币$18.0
《公司业绩》绿竹生物(02480.HK)全年亏损收窄至2.49亿人民币
阿斯达克财经 · 03-17
《公司业绩》绿竹生物(02480.HK)全年亏损收窄至2.49亿人民币
绿竹生物-B(02480.HK)年度经调整亏损增加约46.6%至约2.23亿元
格隆汇资讯 · 03-15
绿竹生物-B(02480.HK)年度经调整亏损增加约46.6%至约2.23亿元
绿竹生物-B盘中异动 早盘快速拉升6.97%报18.421港元
自选股智能写手 · 03-15
绿竹生物-B盘中异动 早盘快速拉升6.97%报18.421港元
绿竹生物-B盘中异动 临近收盘股价大跌6.74%报17.700港元
自选股智能写手 · 03-14
绿竹生物-B盘中异动 临近收盘股价大跌6.74%报17.700港元
绿竹生物-B(02480)股价下跌6.849%,现价港币$17.68
阿斯达克财经 · 03-14
绿竹生物-B(02480)股价下跌6.849%,现价港币$17.68
绿竹生物-B盘中异动 股价大跌5.62%
自选股智能写手 · 03-11
绿竹生物-B盘中异动 股价大跌5.62%
绿竹生物-B盘中异动 股价大跌5.31%
自选股智能写手 · 03-08
绿竹生物-B盘中异动 股价大跌5.31%
绿竹生物-B盘中异动 下午盘股价大跌5.71%
自选股智能写手 · 03-07
绿竹生物-B盘中异动 下午盘股价大跌5.71%
绿竹生物-B(02480)股价上升8.35%,现价港币$21.15
阿斯达克财经 · 03-06
绿竹生物-B(02480)股价上升8.35%,现价港币$21.15
绿竹生物-B(02480.HK)拟3月15日举行董事会会议批准年度业绩
格隆汇资讯 · 03-05
绿竹生物-B(02480.HK)拟3月15日举行董事会会议批准年度业绩
绿竹生物-B盘中异动 急速上涨7.03%
自选股智能写手 · 03-05
绿竹生物-B盘中异动 急速上涨7.03%
加载更多
公司概况
公司名称:
绿竹生物-B
所属市场:
SEHK
上市日期:
--
主营业务:
北京绿竹生物技术股份有限公司是一家主要从事药物发现、研究及开发及商业化的中国公司。该公司还从事对外授权人类疫苗及治疗性生物制剂。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02480","market":"HK","secType":"STK","nameCN":"绿竹生物-B","latestPrice":20.5,"timestamp":1713514115032,"preClose":20.05,"halted":0,"volume":1600,"delay":0,"floatShares":202449032,"shares":202449032,"eps":-1.3547689,"marketStatus":"休市中","marketStatusCode":7,"change":0.45,"latestTime":"04-19 16:08:35","open":20.5,"high":20.5,"low":20.5,"amount":32800,"amplitude":0,"askPrice":20.8,"askSize":200,"bidPrice":20.5,"bidSize":3600,"shortable":0,"etf":0,"ttmEps":-1.35476891941435,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713749400000},"adr":0,"listingDate":1683475200000,"adjPreClose":20.05,"openAndCloseTimeList":[[1713490200000,1713499200000],[1713502800000,1713513600000]],"volumeRatio":1.6,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02480","defaultTab":"news","newsList":[{"id":"2426527659","title":"绿竹生物-B(02480)股价下跌8.061%,现价港币$18.02","url":"https://stock-news.laohu8.com/highlight/detail?id=2426527659","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426527659?lang=zh_cn&edition=full","pubTime":"2024-04-12 14:45","pubTimestamp":1712904300,"startTime":"0","endTime":"0","summary":"[下跌股]绿竹生物-B(02480) 股价在下午02:45比前收市价下跌8.061%,现股价为港币$18.02。至目前为止,今日最高价为$20.0,而最低价为$18.02。总成交量为400股,总成交金额为港币$7604。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152743541_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152743541_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2404123122/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2426271275","title":"绿竹生物-B盘中异动 急速下挫6.13%报18.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426271275","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426271275?lang=zh_cn&edition=full","pubTime":"2024-04-12 14:44","pubTimestamp":1712904261,"startTime":"0","endTime":"0","summary":"2024年04月12日下午盘14时44分,绿竹生物-B股票出现波动,股价快速下跌6.13%。截至发稿,该股报18.400港元/股,成交量200股,换手率0.00%,振幅0.00%。资金方面,该股资金流入4000港元,流出0港元。绿竹生物-B股票所在的生物技术行业中,整体跌幅为0.17%。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412144421861e538d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412144421861e538d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426289170","title":"绿竹生物:LZ901研发稳步推进 未来盈利空间值得期待","url":"https://stock-news.laohu8.com/highlight/detail?id=2426289170","media":"中国财富通","top":-1,"share":"https://www.laohu8.com/m/news/2426289170?lang=zh_cn&edition=full","pubTime":"2024-04-11 14:51","pubTimestamp":1712818311,"startTime":"0","endTime":"0","summary":"根据绿竹生物最近一期的年报显示,公司重磅产品——带状疱疹疫苗LZ901已于2023年9月在中国启动了LZ901的多中心、随机、双盲、安慰剂对照III期临床试验。相比于当下已经上市的同类竞品,绿竹生物的LZ901拥有优秀的表现,副作用更低,同时价格也更具性价比,能够覆盖更广的人群。对于绿竹生物而言,即将上市的LZ901,有望给公司未来业绩带来更多的想象空间。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411145156876603f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411145156876603f0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422302775","title":"绿竹生物-B盘中异动 临近午盘股价大跌5.56%报17.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422302775","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422302775?lang=zh_cn&edition=full","pubTime":"2024-03-25 11:37","pubTimestamp":1711337874,"startTime":"0","endTime":"0","summary":"2024年03月25日临近午盘11时37分,绿竹生物-B股票出现异动,股价急速下跌5.56%。截至发稿,该股报17.000港元/股,成交量1600股,换手率0.00%,振幅0.00%。资金方面,该股资金流入2.88万港元,流出0港元。绿竹生物-B股票所在的生物技术行业中,整体涨幅为1.55%。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032511375487e7b53e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032511375487e7b53e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422307805","title":"绿竹生物-B(02480)股价下跌5.556%,现价港币$17.0","url":"https://stock-news.laohu8.com/highlight/detail?id=2422307805","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422307805?lang=zh_cn&edition=full","pubTime":"2024-03-25 11:37","pubTimestamp":1711337820,"startTime":"0","endTime":"0","summary":"[下跌股]绿竹生物-B(02480) 股价在上午11:37比前收市价下跌5.556%,现股价为港币$17.0。至目前为止,今日最高价为$18.0,而最低价为$17.0。总成交量为1800股,总成交金额为港币$3.22万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240325947/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2421064448","title":"绿竹生物-B盘中异动 急速下挫5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421064448","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421064448?lang=zh_cn&edition=full","pubTime":"2024-03-21 15:40","pubTimestamp":1711006821,"startTime":"0","endTime":"0","summary":"2024年03月21日临近收盘15时40分,绿竹生物-B股票出现异动,股价快速下跌5.32%。绿竹生物-B股票所在的生物技术行业中,整体跌幅为0.17%。绿竹生物-B公司简介:北京绿竹生物技术股份有限公司是一家主要从事药物发现、研究及开发及商业化的中国公司。该公司还从事对外授权人类疫苗及治疗性生物制剂。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403211540217a4e288f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403211540217a4e288f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421062874","title":"绿竹生物-B(02480)股价下跌5.319%,现价港币$17.8","url":"https://stock-news.laohu8.com/highlight/detail?id=2421062874","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2421062874?lang=zh_cn&edition=full","pubTime":"2024-03-21 15:40","pubTimestamp":1711006800,"startTime":"0","endTime":"0","summary":"[下跌股]绿竹生物-B(02480) 股价在下午03:40比前收市价下跌5.319%,现股价为港币$17.8。至目前为止,今日最高价为$18.58,而最低价为$17.8。总成交量为8600股,总成交金额为港币$15.882万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2403212122/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2420798672","title":"绿竹生物-B盘中异动 下午盘股价大跌5.06%报18.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420798672","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420798672?lang=zh_cn&edition=full","pubTime":"2024-03-20 14:51","pubTimestamp":1710917475,"startTime":"0","endTime":"0","summary":"2024年03月20日下午盘14时51分,绿竹生物-B股票出现波动,股价快速下挫5.06%。截至发稿,该股报18.000港元/股,成交量1200股,换手率0.00%,振幅5.06%。资金方面,该股资金流入1.4768万港元,流出7392港元。绿竹生物-B股票所在的生物技术行业中,整体涨幅为0.53%。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032014511587e7a57b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032014511587e7a57b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420331798","title":"绿竹生物-B(02480)股价下跌5.063%,现价港币$18.0","url":"https://stock-news.laohu8.com/highlight/detail?id=2420331798","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2420331798?lang=zh_cn&edition=full","pubTime":"2024-03-20 14:51","pubTimestamp":1710917460,"startTime":"0","endTime":"0","summary":"[下跌股]绿竹生物-B(02480) 股价在下午02:51比前收市价下跌5.063%,现股价为港币$18.0。至目前为止,今日最高价为$18.96,而最低价为$18.0。总成交量为1200股,总成交金额为港币$2.216万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2403201082/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2420481634","title":"《公司业绩》绿竹生物(02480.HK)全年亏损收窄至2.49亿人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2420481634","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2420481634?lang=zh_cn&edition=full","pubTime":"2024-03-17 19:30","pubTimestamp":1710675000,"startTime":"0","endTime":"0","summary":"绿竹生物-B(02480.HK) 公布2023年止年度业绩,其他收入录得2,009万人民币(下同),按年增加44.3%。亏损由上年度7.25亿元,收窄至2.49亿元,每股亏损。不派末期息。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2023/08/21中期业绩无派息AASTOCKS新闻","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20230424170315923_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20230424170315923_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1333949/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2419292973","title":"绿竹生物-B(02480.HK)年度经调整亏损增加约46.6%至约2.23亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419292973","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2419292973?lang=zh_cn&edition=full","pubTime":"2024-03-15 20:19","pubTimestamp":1710505155,"startTime":"0","endTime":"0","summary":"集团的研发开支由截至2022年12月31日止年度的约人民币91.4百万元增加约88.9%至截至2023年12月31日止年度的约人民币172.7百万元,乃主要由于在中国开启LZ901的III期临床试验。期内经调整亏损由截至2022年12月31日止年度的约人民币152.1百万元增加约46.6%至截至2023年12月31日止年度的约人民币222.9百万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403152021048786b70d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403152021048786b70d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419967518","title":"绿竹生物-B盘中异动 早盘快速拉升6.97%报18.421港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419967518","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419967518?lang=zh_cn&edition=full","pubTime":"2024-03-15 09:42","pubTimestamp":1710466973,"startTime":"0","endTime":"0","summary":"2024年03月15日早盘09时42分,绿竹生物-B股票出现异动,股价大幅拉升6.97%。截至发稿,该股报18.421港元/股,成交量600股,换手率0.00%,振幅4.65%。绿竹生物-B股票所在的生物技术行业中,整体跌幅为0.88%。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。消息层面,截至09时42分,绿竹生物-B股票正面舆情新闻比例50%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031509425387e79163&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031509425387e79163&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419628046","title":"绿竹生物-B盘中异动 临近收盘股价大跌6.74%报17.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419628046","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419628046?lang=zh_cn&edition=full","pubTime":"2024-03-14 15:39","pubTimestamp":1710401942,"startTime":"0","endTime":"0","summary":"2024年03月14日临近收盘15时39分,绿竹生物-B股票出现异动,股价急速跳水6.74%。截至发稿,该股报17.700港元/股,成交量0股,换手率0.00%,振幅0.00%。资金方面,该股资金流入0港元,流出0港元。绿竹生物-B股票所在的生物技术行业中,整体涨幅为0.12%。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031415390287e78e6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031415390287e78e6e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419462545","title":"绿竹生物-B(02480)股价下跌6.849%,现价港币$17.68","url":"https://stock-news.laohu8.com/highlight/detail?id=2419462545","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2419462545?lang=zh_cn&edition=full","pubTime":"2024-03-14 15:39","pubTimestamp":1710401940,"startTime":"0","endTime":"0","summary":"[下跌股]绿竹生物-B(02480) 股价在下午03:39比前收市价下跌6.849%,现股价为港币$17.68。至目前为止,今日最高价为$17.68,而最低价为$17.68。总成交量为1000股,总成交金额为港币$1.768万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133703138_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133703138_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2403141742/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2418958388","title":"绿竹生物-B盘中异动 股价大跌5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418958388","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418958388?lang=zh_cn&edition=full","pubTime":"2024-03-11 14:32","pubTimestamp":1710138761,"startTime":"0","endTime":"0","summary":"2024年03月11日下午盘14时32分,绿竹生物-B股票出现波动,股价快速下跌5.62%。截至发稿,该股报18.500港元/股,成交量200股,换手率0.00%,振幅0.00%。绿竹生物-B股票所在的生物技术行业中,整体涨幅为0.99%。绿竹生物-B公司简介:北京绿竹生物技术股份有限公司是一家主要从事药物发现、研究及开发及商业化的中国公司。该公司还从事对外授权人类疫苗及治疗性生物制剂。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031114324187e77af6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031114324187e77af6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417705125","title":"绿竹生物-B盘中异动 股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417705125","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417705125?lang=zh_cn&edition=full","pubTime":"2024-03-08 13:32","pubTimestamp":1709875932,"startTime":"0","endTime":"0","summary":"2024年03月08日下午盘13时32分,绿竹生物-B股票出现波动,股价大幅下跌5.31%。绿竹生物-B股票所在的生物技术行业中,整体涨幅为0.82%。其相关个股中,博安生物、嘉和生物-B、北海康成-B涨幅较大,振幅较大的相关个股有宜明昂科-B、博安生物、北海康成-B,振幅分别为40.33%、38.81%、24.14%。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403081332127a4ab94d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403081332127a4ab94d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417785604","title":"绿竹生物-B盘中异动 下午盘股价大跌5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417785604","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417785604?lang=zh_cn&edition=full","pubTime":"2024-03-07 14:00","pubTimestamp":1709791236,"startTime":"0","endTime":"0","summary":"2024年03月07日下午盘14时00分,绿竹生物-B股票出现异动,股价大幅跳水5.71%。绿竹生物-B股票所在的生物技术行业中,整体跌幅为3.33%。绿竹生物-B公司简介:北京绿竹生物技术股份有限公司是一家主要从事药物发现、研究及开发及商业化的中国公司。该公司还从事对外授权人类疫苗及治疗性生物制剂。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030714003687e76dd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030714003687e76dd4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417123776","title":"绿竹生物-B(02480)股价上升8.35%,现价港币$21.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2417123776","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2417123776?lang=zh_cn&edition=full","pubTime":"2024-03-06 15:28","pubTimestamp":1709710080,"startTime":"0","endTime":"0","summary":"[上升股]绿竹生物-B(02480) 股价在下午03:28比前收市价上升8.35%,现股价为港币$21.15。至目前为止,今日最高价为$21.15,而最低价为$17.62。总成交量为2.14万股,总成交金额为港币$39.127万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2403064965/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2417346547","title":"绿竹生物-B(02480.HK)拟3月15日举行董事会会议批准年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2417346547","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2417346547?lang=zh_cn&edition=full","pubTime":"2024-03-05 16:37","pubTimestamp":1709627872,"startTime":"0","endTime":"0","summary":"格隆汇3月5日丨绿竹生物-B(02480.HK)发布公告,公司将于2024年3月15日(星期五)举行董事会会议,以(其中包括)考虑及批准集团截至2023年12月31日止年度的全年业绩以及考虑派发末期股息(如有)的建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403051638008752c3fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403051638008752c3fd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417489255","title":"绿竹生物-B盘中异动 急速上涨7.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417489255","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417489255?lang=zh_cn&edition=full","pubTime":"2024-03-05 09:34","pubTimestamp":1709602484,"startTime":"0","endTime":"0","summary":"2024年03月05日早盘09时34分,绿竹生物-B股票出现波动,股价急速上涨7.03%。绿竹生物-B股票所在的生物技术行业中,整体涨幅为0.12%。绿竹生物-B公司简介:北京绿竹生物技术股份有限公司是一家主要从事药物发现、研究及开发及商业化的中国公司。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240305093444861db1bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240305093444861db1bf&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://luzhubiotech.com","stockEarnings":[{"period":"1week","weight":0.0567},{"period":"1month","weight":0.0904},{"period":"3month","weight":-0.2794},{"period":"6month","weight":-0.3797},{"period":"1year","weight":-0.375},{"period":"ytd","weight":-0.3144}],"compareEarnings":[{"period":"1week","weight":-0.0298},{"period":"1month","weight":-0.0193},{"period":"3month","weight":0.0598},{"period":"6month","weight":-0.0552},{"period":"1year","weight":-0.2046},{"period":"ytd","weight":-0.0483}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京绿竹生物技术股份有限公司是一家主要从事药物发现、研究及开发及商业化的中国公司。该公司还从事对外授权人类疫苗及治疗性生物制剂。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","exchange":"SEHK","name":"绿竹生物-B","nameEN":"LUZHU BIOTECH-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"绿竹生物-B(02480)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供绿竹生物-B(02480)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"绿竹生物-B,02480,绿竹生物-B股票,绿竹生物-B股票老虎,绿竹生物-B股票老虎国际,绿竹生物-B行情,绿竹生物-B股票行情,绿竹生物-B股价,绿竹生物-B股市,绿竹生物-B股票价格,绿竹生物-B股票交易,绿竹生物-B股票购买,绿竹生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"绿竹生物-B(02480)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供绿竹生物-B(02480)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}